Akebia Therapeutics Inc (NASDAQ:AKBA)

1.14
Delayed Data
As of Oct 02
 0.00 / 0.00%
Today’s Change
0.24
Today|||52-Week Range
1.84
+97.57%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close1.14
Today’s open1.12
Day’s range1.11 - 1.16
Volume32,155
Average volume (3 months)1,851,091
Market cap$212.8M
Data as of 3:59pm ET, 10/02/2023

Growth & Valuation

Earnings growth (last year)+69.75%
Earnings growth (this year)+46.08%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+36.94%
P/E ratioNM
Price/Sales0.36
Price/Book39.79

Competitors

----
----
STROSutro Biopharma Inc+0.01+0.43%
----
Data as of 4:00pm ET, 10/02/2023

Financials

Next reporting dateNovember 9, 2023
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$292.5M
Annual profit (last year)-$94.2M
Net profit margin-32.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts